Develo, a Los Angeles, CA-based AI-native operating system for pediatrics, has raised $14 million in funding. 

Investors 

The funding round was led by Blueprint Equity, with participation from Villain Capital, Z21 Ventures, Bienville Capital, and several healthcare technology angel investors. 

Blueprint Equity is a San Diego-based growth equity firm that specializes in partnering with founder-led, capital-efficient technology companies. Founded in 2018, the firm manages over $600 million in assets and focuses on capital-efficient B2B SaaS and fintech businesses. 

Develo Use of Funds 

The company will use the capital to support growth initiatives, expand R&D efforts, and strengthen customer success operations. 

About Develo 

Founded in 2022 by Aaron Sin, MD, and Han Ke, Develo is a healthcare technology company developing the first AI-native operating system purpose-built for pediatric care. Its platform unifies clinical workflows, billing, intake, family engagement, and reporting into a single AI-driven system designed specifically for pediatric practices. Develo’s platform integrates features such as AI scribes, automated pediatric charge capture, and intelligent reporting to reduce administrative burden and improve care experiences for providers, patients, and families. The company currently supports hundreds of pediatric providers across more than two dozen U.S. states. 

Funding Details 

Company: Develo, Inc. 

Raised: $14.0M 

Round: Growth Round 

Funding Date: May 2026 

Lead Investor: Blueprint Equity 

Additional Investors: Villain Capital, Z21 Ventures, Bienville Capital, Chris Sullens, Chris Barton, Paul Black 

Company Website: https://develo.com/  

Software Category: Healthcare AI / Pediatric EMR Software 

Source: Develo